阿门托弗拉通过向ClpP对MRSA的毒性产生抑制作用
Teri Gele1, Xiangri Kong2, Qiuyue Zhang3
1Changchun University of Chinese Medicine, Changchun, China.
Journal of cellular and molecular medicine
|October 22, 2025
概括
通过向ClpP,AMF有效地抑制了抗甲素黄金葡萄球菌 (MRSA) 的毒性,减少了毒素的产生和生物膜的形成. 这种抗病毒策略对治疗MRSA感染而不会伤害有益细菌有前途.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 甲素耐药黄金葡萄球菌 (MRSA) 由于其越来越多的毒性和抗生素耐药性,对全球健康构成重大威胁.
- 针对细菌毒性因素,而不是基本的生存机制,提供了一个有希望的抗病毒策略,以对抗耐药性病原体.
- ClpP蛋白酶是许多细菌中毒性的关键调节者,包括MRSA,这使其成为一个有吸引力的治疗点.
研究的目的:
- 通过向ClpP蛋白酶,研究一种新型化合物AMF作为MRSA毒性抑制剂的作用机制.
- 评估AMF在降低MRSA毒性因子方面的有效性,包括血液溶解活性和生物膜形成,在体外和体内.
- 在MRSA肺炎的小鼠模型中评估AMF的治疗潜力.
主要方法:
- 用分子动力学模拟,弗斯特共振能量转移 (FRET) 和热转移试验 (TSA) 来研究AMF-ClpP相互作用.
- 进行了表型测定,以测量MRSA血解活性,生物膜形成和细菌生长.
- 在体内研究包括一种小鼠肺炎模型,以评估生存率,细胞因子水平和肺组织损伤.
主要成果:
- AMF显著抑制了MRSA血解活性 (72%) 和生物膜形成 (58%),但没有影响细菌生长.
- 分子对接和CETSA确定了AMF和ClpP (ARG-171,ASP-170,ASP-172) 之间的关键相互作用点.
- 在小鼠中,AMF治疗改善了从20%到75%的生存率,并减少了促炎细胞因子,减轻了肺损伤.
结论:
- 亚米是一种强大的ClpP抑制剂,通过双重机制有效减弱MRSA的毒性:抑制毒素产生和生物膜形成.
- 亚美菌显示出作为抗MRSA感染的抗病毒剂的显著治疗潜力,为传统抗生素提供了一个有希望的替代品.
- 向ClpP代表了一种可行的抗病毒策略,用于对抗具有挑战性的细菌病原体,如MRSA,并保护宿主微生物群.
更多相关视频
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
7.6K
07:47Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
12.0K
相关概念视频
01:28Gene Regulation in Microbial Communities: Quorum Sensing
517
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
517
01:23Antimicrobial Proteins
13.0K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
13.0K
01:28Antimicrobial Effectiveness
898
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
898
01:18Surface Membrane Barriers
2.6K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
2.6K